Does LAROTRECTINIB Cause Decreased appetite? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Decreased appetite have been filed in association with LAROTRECTINIB (VITRAKVI). This represents 0.6% of all adverse event reports for LAROTRECTINIB.
5
Reports of Decreased appetite with LAROTRECTINIB
0.6%
of all LAROTRECTINIB reports
1
Deaths
1
Hospitalizations
How Dangerous Is Decreased appetite From LAROTRECTINIB?
Of the 5 reports, 1 (20.0%) resulted in death, 1 (20.0%) required hospitalization.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for LAROTRECTINIB.
What Other Side Effects Does LAROTRECTINIB Cause?
Fatigue (56)
Drug ineffective (52)
Dizziness (50)
Death (48)
Pain (42)
Neuropathy peripheral (39)
Nausea (32)
Off label use (31)
Disease progression (27)
Malignant neoplasm progression (23)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which LAROTRECTINIB Alternatives Have Lower Decreased appetite Risk?
LAROTRECTINIB vs LASILIX
LAROTRECTINIB vs LASIX
LAROTRECTINIB vs LASMIDITAN
LAROTRECTINIB vs LATANOPROST
LAROTRECTINIB vs LATANOPROSTENE BUNOD